Effects of long-term transdermal administration of estradiol on serum lipids

Mayo Clinic Proceedings

Volumn 73, Issue 8, 1998, Pages 735-738

  Ory, Steven J ^a   Field, Charles S ^b   Herrmann, Rebekah R ^c   Zinsmeister, Alan R ^d   Lawrence Riggs, B ^b  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b Section of Biostatistics   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d Northwestern Center for Infertility and Reproductive Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BONE METABOLISM; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031822132     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.8.735     Document Type: Article

References (12)

1. Ross RK, Pike MC, Mack TM, Henderson BE. Oestrogen replacement therapy and cardiovascular disease. In: Drife JO, Studd JWW, editors. HRT and Osteoporosis. London: Springer-Verlag; 1990. pp 209-222
2. Pfeffer RI, Kurosaki TT, Charlton SK. Estrogen use and blood pressure in later life. Am J Epidemiol 1979;110:469-478
3. Ross RK, Paganini-Hill A, Mack TM, Henderson BE. Estrogen use and cardiovascular disease. In: Mishell DR Jr, editor. Menopause: Physiology and Pharmacology. Chicago: Year Book Medical Publishers; 1987. pp 209-223
4. Chetkowski RJ, Meldrum DR, Steingold KA, Rändle D, Lu JK, Eggena P, et al. Biologie effects of transdermal estradiol. N Engl J Med 1986:314:1615-1620
5. Field CS, Ory SJ, Wahner HW, Herrmann RR, Judd HL, Riggs BL. Preventive effects of transdermal 17-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol 1993:168:114-121
6. Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-1024
7. Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period. Obstet Gynecol 1988:71:671-676
8. Walsh BW, Schiff l, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204
9. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA. A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 1988;159:1540-1546
10. Pang SC, Greendale GA, Cedars Ml, Gambone JC, Lozano K, Eggena P, et al. Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil Steril 1993:59:76-82
11. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 1990:10:1051-1057
12. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-1867